News
-
-
-
-
-
PRESS RELEASE
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
ABIONYX Pharma communique le nombre de droits de vote et d'actions en circulation, conformément aux exigences de l'AMF. La société se consacre au développement de biomédicaments novateurs pour les maladies inflammatoires les plus sévères -
PRESS RELEASE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Monthly statement of total voting rights and shares for ABIONYX Pharma on Euronext Paris, including total gross and net voting rights as of April 30, 2025 -
-
-
-
PRESS RELEASE
Inside Information / Other news releases
CIC Market Solutions initiates buy coverage of ABIONYX Pharma. ABIONYX Pharma, a next-generation biopharma dedicated to innovative biomedicines based on recombinant apoA-I for severe inflammatory diseases, receives Buy recommendation from CIC Market Solutions
